Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. [Review]

MedStar author(s):
Citation: Cardiovascular Revascularization Medicine. 15(2):109-16, 2014 Mar.PMID: 24684760Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Absorbable Implants | *Coronary Artery Disease/th [Therapy] | *Endovascular Procedures/is [Instrumentation] | *Percutaneous Coronary Intervention/is [Instrumentation] | *Peripheral Arterial Disease/th [Therapy] | *Stents | *Tissue Scaffolds | Animals | Coronary Artery Disease/di [Diagnosis] | Drug-Eluting Stents | Endovascular Procedures/ae [Adverse Effects] | Humans | Metals | Percutaneous Coronary Intervention/ae [Adverse Effects] | Peripheral Arterial Disease/di [Diagnosis] | Prosthesis Design | Treatment OutcomeYear: 2014Local holdings: Available in print through MWHC library: 2002 - presentISSN:
  • 1878-0938
Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds. Copyright © 2014. Published by Elsevier Inc.All authors: Kitabata H, Waksman R, Warnack BFiscal year: FY2014Digital Object Identifier: Date added to catalog: 2016-05-24
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 24684760 Available 24684760

Available in print through MWHC library: 2002 - present

Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds. Copyright © 2014. Published by Elsevier Inc.

English

Powered by Koha